Education
About Us
Working with TipRanks
Follow Us
Orion Nutraceuticals, Inc. (TSE:ORI)
:ORI
RESEARCH TOOLSreports
Total Valuation
Orion Nutraceuticals has a market cap or net worth of C$797.31K. The enterprise value is ―.
Market CapC$797.31K
Enterprise Value―
Share Statistics
Orion Nutraceuticals has 29,307,964 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding29,307,964
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Orion Nutraceuticals’s return on equity (ROE) is 0.06 and return on invested capital (ROIC) is 35.37%.
Return on Equity (ROE)0.06
Return on Assets (ROA)-0.32
Return on Invested Capital (ROIC)35.37%
Return on Capital Employed (ROCE)0.32
Revenue Per Employee―
Profits Per Employee-10.00T>
Employee Count―
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Orion Nutraceuticals is -189.63. Orion Nutraceuticals’s PEG ratio is 0.03.
PE Ratio-189.63
PS Ratio0.00
PB Ratio-11.02
Price to Fair Value-12.01
Price to FCF-122.64
Price to Operating Cash Flow-122.64
PEG Ratio0.03
Income Statement
In the last 12 months, Orion Nutraceuticals had revenue of 0.00 and earned -61.82K in profits. Earnings per share was 0.00.
Revenue0.00
Gross Profit0.00
Operating Income-316.36K
Pretax Income-61.82K
Net Income-61.82K
EBITDA-61.82K
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was -95.59K and capital expenditures 0.00, giving a free cash flow of -95.59K billion.
Operating Cash Flow-95.59K
Free Cash Flow-95.59K
Free Cash Flow per Share>-0.01
Dividends & Yields
Orion Nutraceuticals pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.00
52-Week Price Change0.00%
50-Day Moving Average0.40
200-Day Moving Average0.40
Relative Strength Index (RSI)100.00
Average Volume (3m)0.00
Important Dates
Orion Nutraceuticals upcoming earnings date is Sep 25, 2025, TBA Not Confirmed.
Last Earnings DateApr 18, 2025
Next Earnings DateSep 25, 2025
Ex-Dividend Date―
Financial Position
Orion Nutraceuticals as a current ratio of 0.17, with Debt / Equity ratio of -4.22%
Current Ratio0.17
Quick Ratio0.17
Debt to Market Cap<0.01
Net Debt to EBITDA1.80
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Orion Nutraceuticals has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Orion Nutraceuticals EV to EBITDA ratio is -187.83, with an EV/FCF ratio of -203.95.
EV to Sales0.00
EV to EBITDA-187.83
EV to Free Cash Flow-203.95
EV to Operating Cash Flow-203.95
Balance Sheet
Orion Nutraceuticals has C$97.34K in cash and marketable securities with C$44.91K in debt, giving a net cash position of -C$52.44K billion.
Cash & Marketable SecuritiesC$97.34K
Total DebtC$44.91K
Net Cash-C$52.44K
Net Cash Per Share>-C$0.01
Tangible Book Value Per Share-C$0.03
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Orion Nutraceuticals is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast-314.29%